Упрощенная HTML-версия
166
208. CD4 + CD25 bright T cells in human intestinal lamina propria as
regulatory cells / S. Makita [et al.] // J. Immunol.-2004.-Vol. 173, №5. -P.3119-3130.
209. Cell proliferation and death in the gastric epithelium of developing rats
after glucocorticoid treatments / P. Gama [et al.] // Anat. Rec. – 2000. – Vol. 260, №
3. – P. 213-221.
210. Chemopreventive effect of Ginkgo biloba extract against benzo(a)pyrene-
induced forestomach carcinogenesis in mice: amelioration of doxorubicin
cardiotoxicity / A.M. Agha [et al.] // J. Exp. Clin. Cancer Res. – 2001. – Vol. 20, №
1. – P. 39-50.
211. Chemotherapy for operable gastric cancer: results of the Dutch randomized
FAMTX trial. The Dutch Gastric Cancer Group (DGCG) / I. Songun [et al.] // Eur. J.
Cancer. – 1999. – Vol. 35, № 4. – P. 558-562.
212. Chow F.S. Modeling interactions between adrenal suppression and T-
helper lymphocyte trafficking during multiple dosing of methylprednisolone / F.S.
Chow, A. Sharma, W.J. Jusko // J. Pharmacokinet. Biopharm. – 1999. – Vol. 27, №
6. – P. 559-575.
213. Clinical trial of rubidazone in advanced squamous cell carcinoma of the
lung and adenocarcinoma of the large intestine / R.J. Fraile [et al.] // Cancer Treat.
Rep. – 1978. – Vol. 62, №10. – P. 1599-1601.
214. Corticosteroids impair intestinal epithelial wound repair mechanisms in
vitro / S. Jung [et al.] // Scand. J. Gastroenterol. – 2001. – Vol. 36, № 9. – P. 963-970.
215. Current drug therapy for MM / Y.W. Huang [et al.] // Drugs. – 1999. – Vol.
57, № 4. – P. 485-506.
216. Cyclophosphamide
augments
inflammation
by
reducing
immunosuppression in a mouse model of allergic airway disease / Y.C. Su [et al.] // J.
Allergy Clin. Immunol. – 2006. – Vol. 117, № 3. – P. 635-641.
217. Cyclophosphamide decreases the number, percentage and the function of
CD 25+ CD 4+ regulatory T cells, which suppress induction of contact
hypersensitivity / Y. Ikezawa [et al.] // J. Dermatol. Sci. – 2005. – Vol. 39, № 2. – P.
105-112.